to Explore
Alteogen is a leading biotechnology company focused on research and development of
next-generation biobetters with improved features over existing biologics,
and biosimilars by utilizing its proprietary platform technologies.
Next generation long-acting technology which utilizes human A1AT (alpha-1 anti-trypsin)
protein that is abundant in human blood as the protein carrier
Proprietary antibody-drug conjugate (ADC) technology with
superior stability, efficacy, and cost-effectiveness
Higher stability hyaluronidase that enables large volume intravenous (IV) infusions
to subcutaneous (SC) injections
Alteogen is committed to developing high-quality biopharmaceuticals to enhance the quality of life for people around the world.
Alteogen leverages our core technological expertise, uphold our social responsibilities, and operate on a foundation of sustainable management.
-
- Environmental
-
Alteogen practices eco-friendly management systematically
complying all relevant regulations.
-
- Social
-
Alteogen has established “Alteogen Human Rights Charter
and Implementation Guidelines”.
-
- Governance
-
Alteogen strives to uphold strong corporate governance
by adhering to business ethics.
